122 related articles for article (PubMed ID: 30224918)
41. Prognostic significance of young age in papillary thyroid carcinoma: analysis of 5,733 patients with 150 months' median follow-up.
Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
Endocr J; 2014; 61(5):491-7. PubMed ID: 24553476
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications.
Jukkola A; Bloigu R; Ebeling T; Salmela P; Blanco G
Endocr Relat Cancer; 2004 Sep; 11(3):571-9. PubMed ID: 15369456
[TBL] [Abstract][Full Text] [Related]
43. Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression.
Sohn SY; Joung JY; Cho YY; Park SM; Jin SM; Chung JH; Kim SW
Endocrinol Metab (Seoul); 2015 Sep; 30(3):343-51. PubMed ID: 26248858
[TBL] [Abstract][Full Text] [Related]
44. Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer.
Alzahrani AS; Mohamed G; Al Shammary A; Aldasouqi S; Abdal Salam S; Shoukri M
J Endocrinol Invest; 2005 Jun; 28(6):540-6. PubMed ID: 16117196
[TBL] [Abstract][Full Text] [Related]
45. [Influence of lymphocitic thyroiditis on prognostic outcome differentiated thyroid carcinoma].
Filipović A; Paunović I; Vucković Lj
Acta Chir Iugosl; 2010; 57(2):85-94. PubMed ID: 20954315
[TBL] [Abstract][Full Text] [Related]
46. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
[TBL] [Abstract][Full Text] [Related]
47. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
Zaman SU; Awan MS; Sulaiman MA
Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
[TBL] [Abstract][Full Text] [Related]
48. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
49. Identification of a cut-off for the MACIS score to predict the prognosis of differentiated thyroid carcinoma in children and young adults.
Jang HW; Lee JI; Kim HK; Oh YL; Choi YL; Jin DK; Kim JH; Chung JH; Kim SW
Head Neck; 2012 May; 34(5):696-701. PubMed ID: 21748817
[TBL] [Abstract][Full Text] [Related]
50. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
[TBL] [Abstract][Full Text] [Related]
51. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.
Grubbs EG; Williams MD; Scheet P; Vattathil S; Perrier ND; Lee JE; Gagel RF; Hai T; Feng L; Cabanillas ME; Cote GJ
Thyroid; 2016 Nov; 26(11):1553-1562. PubMed ID: 27610696
[TBL] [Abstract][Full Text] [Related]
52. Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications.
Morbelli S; Ferrarazzo G; Pomposelli E; Pupo F; Pesce G; Calamia I; Fiz F; Clapasson A; Bauckneht M; Minuto M; Sambuceti G; Giusti M; Bagnasco M
J Endocrinol Invest; 2017 Apr; 40(4):417-424. PubMed ID: 27844413
[TBL] [Abstract][Full Text] [Related]
53. Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients.
Horvatic Herceg G; Herceg D; Kralik M; Kulic A; Bence-Zigman Z; Tomic-Brzac H; Bracic I; Kusacic-Kuna S; Prgomet D
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):533-40. PubMed ID: 23835563
[TBL] [Abstract][Full Text] [Related]
54. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?
Amit M; Boonsripitayanon M; Goepfert RP; Tam S; Busaidy NL; Cabanillas ME; Dadu R; Varghese J; Waguespack SG; Gross ND; Graham P; Williams MD; Sturgis EM; Zafereo ME
Ann Surg Oncol; 2018 Oct; 25(11):3380-3388. PubMed ID: 30022274
[TBL] [Abstract][Full Text] [Related]
55. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
[TBL] [Abstract][Full Text] [Related]
56. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity.
Wong RL; Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Aug; 19(8):2635-42. PubMed ID: 22526904
[TBL] [Abstract][Full Text] [Related]
59. Death from thyroid cancer of follicular cell origin.
Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
[TBL] [Abstract][Full Text] [Related]
60. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
